Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018 episode artwork

EPISODE · Sep 25, 2018 · 37 MIN

Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018

from PIWORLD Investor Podcasts · host piworld

the full video can be seen at: https://www.piworld.co.uk/2018/09/25/amryt-pharma-amyt-investor-presentation-at-sharesoc-september-2018/ Presentation by Amryt Pharma CCO, David Allmond. Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses. The team – 00:27 The vision - 02:12 Amryt overview – 04:04 Commercial & development pipeline - 06:00 Strategy – 3 pillars of growth - 07:43 Lojuxta - 10:02 Epidermolysis Bullosa (EB) AP101 - 12:20 AP103 – building an EB franchise - Gene Therapy Platform - 18:26 In-License Opportunities - 21:07 Financials - 22:16 Investment case - 22:55 Q&A - 24:18

Episode metadata supplied by the publisher feed · Published Sep 25, 2018

Embed this episode

NOW PLAYING

Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018

0:00 37:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PIWORLD Investor Podcasts?

This episode is 37 minutes long.

When was this PIWORLD Investor Podcasts episode published?

This episode was published on September 25, 2018.

Can I download this PIWORLD Investor Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!